Nymox Pharmaceutical Corporation will sponsor the Third Manhattan Alzheimer Disease Conference in New York on November 28, 2001. It was rescheduled after the September 11 disaster at the World Trade Center.

As at the earlier Manhattan Conferences, the 2001 Conference will have significant new research advances made public for the first time. The Conference will have a special focus on the medical, social and ethical ramifications of the new emerging diagnostics, in particular in the a

Register to view the full article

Register for MeetingsNet.com and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.